Allergan Files 3rd-Party Claims Against Pfizer In Opioid MDL
Law360 (August 2, 2018, 5:43 PM EDT) -- Allergan Finance LLC has hit Pfizer Inc. and a subsidiary with third-party claims in multidistrict litigation over the opioid crisis, arguing that Allergan should be indemnified for having to defend pre-2009 misleading marketing allegations relating to a prescription opioid.
The third-party complaint was filed against Pfizer and its subsidiary King Pharmaceuticals LLC on Wednesday, with Allergan saying it should be indemnified for what it has had to spend on lawsuits regarding the alleged improper marketing of the drug Kadian before 2009. Allergan said that it is the successor company to Actavis, which had entered into a deal in December 2008 to...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!